Your browser doesn't support javascript.
loading
[Omission factors in detecting early stage prostate cancer by TRUS needle biopsy].
Zhang, Shi-Wei; Guo, Hong-Qian; Gan, Wei-Dong; Gong, Zhen-Hua; Sun, Ze-Yu.
Afiliação
  • Zhang SW; Department of Urology, Nanjing Drum Tower Hospital, Nanjing University Medical College, Nanjing, Jiangsu 210008, China. zswzy456@sohu.com
Zhonghua Nan Ke Xue ; 11(6): 431-2, 437, 2005 Jun.
Article em Zh | MEDLINE | ID: mdl-15999487
ABSTRACT

OBJECTIVE:

To analyze and reduce the omission factors in detecting early stage prostate cancer by TRUS needle biopsy, and to improve the diagnosis of the disease.

METHODS:

A total of 80 benign prostatic hyperplasia patients suspected of prostatic carcinoma underwent TRUS sextant biopsies. The pathological results being negative, the patients received transurethral resection of the prostate (TURP).

RESULTS:

After TURP, 25 cases were pathologically diagnosed as prostate cancer, with an omission rate of 31.25% (25/80). Of the diagnosed cancer patients, 10 were treated by radical perineum prostatectomy, 8 by surgical castration, and 7 by medical castration.

CONCLUSION:

Some tumors may fail to be detected by TRUS needle biopsy. Serial or multi-core needle biopsies can decrease the omission rate in the diagnosis of organ confined cancer.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata Idioma: Zh Ano de publicação: 2005 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata Idioma: Zh Ano de publicação: 2005 Tipo de documento: Article